Cargando…
Low ALT Levels Associated with Poor Outcomes in 8700 Hospitalized Heart Failure Patients
Sarcopenia and frailty are causes for morbidity and mortality amongst heart failure (HF) patients. Low alanine transaminase (ALT) is a marker for these syndromes and, therefore, could serve as a biomarker for the prognostication of HF patients. We performed a retrospective analysis of all consecutiv...
Autores principales: | Segev, Amitai, Itelman, Edward, Avaky, Chen, Negru, Liat, Shenhav-Saltzman, Gilat, Grupper, Avishay, Wasserstrum, Yishay, Segal, Gad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600048/ https://www.ncbi.nlm.nih.gov/pubmed/33008125 http://dx.doi.org/10.3390/jcm9103185 |
Ejemplares similares
-
Frailty and Sarcopenia Assessment upon Hospital Admission to Internal Medicine Predicts Length of Hospital Stay and Re-Admission: A Prospective Study of 980 Patients
por: Anani, Sapir, et al.
Publicado: (2020) -
Characterization of heart failure patients with reverse left ventricular remodelling post‐angiotensin receptor blockers/neprilysin inhibitors therapy
por: Maizels, Leonid, et al.
Publicado: (2022) -
Effect of levosimendan infusion prior to left ventricular assist device implantation on right ventricular failure
por: Segev, Amitai, et al.
Publicado: (2022) -
Low ALT blood levels are associated with lower baseline fitness amongst participants of a cardiac rehabilitation program
por: Kogan, Michael, et al.
Publicado: (2018) -
Baseline low ALT activity is associated with increased long-term mortality after COPD exacerbations
por: Lasman, N., et al.
Publicado: (2020)